BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹220 Cr | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr |
What is the latest Total Current Liabilities ratio of BAL PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹220 Cr |
Mar2024 | ₹203 Cr |
Mar2023 | ₹209 Cr |
Mar2022 | ₹166 Cr |
Mar2021 | ₹153 Cr |
How is Total Current Liabilities of BAL PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹220 Cr | 8.10 | |
Mar2024 | ₹203 Cr | -3.00 | |
Mar2023 | ₹209 Cr | 26.38 | |
Mar2022 | ₹166 Cr | 8.60 | |
Mar2021 | ₹153 Cr | - |
Compare Total Current Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹133.1 Cr | -0.7% | -4% | -34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹381,686.0 Cr | -2.5% | -0.2% | -15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,241.0 Cr | -5.9% | -6.9% | 5.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,339.0 Cr | -1.9% | 0.7% | 3.9% | Stock Analytics | |
CIPLA | ₹120,240.0 Cr | -2.6% | -6.4% | -8.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,091.0 Cr | -5.6% | -2.2% | -6.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -0.7% |
-4% |
-34.1% |
SENSEX | -2.2% |
0.4% |
-5.4% |
You may also like the below Video Courses